The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer; BMS GmbH & Co. KG; MSD; Transgene
Consulting or Advisory Role - Achilles Therapeutics; Amgen; AstraZeneca; BMS GmbH & Co. KG; Boxer Capital; Celgene; EQRx; Immumutep; Ixogen; Janssen; Merck; Oxford VacMedix; PharmaMar; Roche; Ultrahuman
Travel, Accommodations, Expenses - Achilles Therapeutics; BMS GmbH & Co. KG; Janssen; MSD; Roche; Takeda
Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial.
 
David James Pinato
Honoraria - Avammune; Bristol-Myers Squibb; Da Volterra; Lift Biosciences; Mursla Bio; Roche/Genentech; Starpharma
Consulting or Advisory Role - AstraZeneca; Da Volterra; EISAI; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley
 
Robert Hugh Jones
Honoraria - Starpharma
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - SERVIER
 
Martin D. Forster
No Relationships to Disclose
 
Anthony M. Joshua
Stock and Other Ownership Interests - Pricilium Therapeutics
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); IDEAYA Biosciences (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Cancer therapeutic methods
 
James Korolewicz
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Sarah Benafif
No Relationships to Disclose
 
Karam Aboud
No Relationships to Disclose
 
Jia (Jenny) Liu
Honoraria - MSD; Specialised Therapeutics
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - ImmVirX; Starpharma
 
Rasha Cosman
Employment - St Vincent's Hospital
Research Funding - St Vincent's Hospital
 
Jeremy Paull
Employment - Starpharma
Leadership - Starpharma
Stock and Other Ownership Interests - Starpharma
Patents, Royalties, Other Intellectual Property - Starpharma
 
Jacinth Fairley
Employment - Starpharma
Leadership - Starpharma
Stock and Other Ownership Interests - Starpharma
Patents, Royalties, Other Intellectual Property - Starpharma
Travel, Accommodations, Expenses - Starpharma
(OPTIONAL) Uncompensated Relationships - Starpharma
 
Stephanie Ruth Edmondson
Employment - Starpharma
Stock and Other Ownership Interests - Starpharma
Patents, Royalties, Other Intellectual Property - Starpharma
 
James F. Spicer
Stock and Other Ownership Interests - IGEM Therapeutics
Consulting or Advisory Role - Apobec Discovery (Inst); Avacta Life Sciences (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Roche (Inst)
Research Funding - Achilles Therapeutics (Inst); BerGenBio (Inst); BluPrint Oncology (Inst); BluPrint Oncology (Inst); Bristol-Myers Squibb (Inst); Genmab (Inst); IO Biotech (Inst); Roche (Inst); RS Oncology (Inst); Starpharma (Inst); Trizell (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Janssen